期刊
RADIOTHERAPY AND ONCOLOGY
卷 117, 期 1, 页码 44-48出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2015.08.011
关键词
Lung cancer; Quality of life; Patient reported outcomes; SABR; SBRT; Surgery
资金
- Netherlands Health Organization for Health Research
We report quality of life and indirect costs from patient reported outcomes from the ROSEL randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as stereotactic body radiotherapy or SBRT) versus surgical resection for medically operable stage IA non-small cell lung cancer. ROSEL closed prematurely after accruing and randomizing 22 patients. This exploratory analysis found the global health related quality of life and indirect costs to be significantly favorable and cheaper, with SABR. (C) 2015 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据